Similar Items
-
P15-21. Investigating the utility and relevance of the good participatory practice guidelines for biomedical HIV prevention trials
by: Feuer C, et al.
Published: (2009-10-01) -
P15-08. Did unblinding affect HIV risk behaviour and risk perception in the HVTN503/Phambili study?
by: Moodie Z, et al.
Published: (2009-10-01) -
Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120.
by: Allan C deCamp, et al.
Published: (2017-01-01) -
HIV Vaccine Research Agenda: Perspectives of an HVTN Site Investigator
by: Blattner William A
Published: (2005-12-01) -
P15-03. HIV vaccine funding trends entering a global recession: research and development (R&D) from 2000 – 2008
by: Vuthoori S, et al.
Published: (2009-10-01)